Characterization of Drug-metabolizing Enzymes CYP2C9, CYP2C19 Polymorphisms in Tunisian, Kuwaiti and Bahraini Populations

Overview

Journal J Genet

Specialty Genetics

Date 2015 Dec 23

PMID 26690534

Citations 7

Authors

Rania Abdelhedi

Nouha Abdelmoula Bouayed

Suad AlFadhli

Leila Abid

Ahmed Rebai

Najla Kharrat

Affiliations

Soon will be listed here.

Citing Articles

Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach.

Alonso Llorente A, Salgado Garrido J, Teijido Hermida O, Gonzalez Andrade F, Valiente Martin A, Fanlo Villacampa A Heliyon. 2024; 10(7):e28566.

PMID: 38586400 PMC: 10998100. DOI: 10.1016/j.heliyon.2024.e28566.

Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.

Alqasrawi M, Al-Mahayri Z, Alblooshi H, AlSafar H, Ali B Curr Vasc Pharmacol. 2024; 22(3):218-229.

PMID: 38284696 DOI: 10.2174/0115701611283841231227064343.

Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.

Ammar H, Chadli Z, Mhalla A, Khouadja S, Hannachi I, Alshaikheid M Pharmacogenomics J. 2021; 21(5):551-558.

PMID: 33731885 DOI: 10.1038/s41397-021-00231-x.

A review of clinical pharmacogenetics Studies in African populations.

Radouani F, Zass L, Hamdi Y, da Rocha J, Sallam R, Abdelhak S Per Med. 2020; 17(2):155-170.

PMID: 32125935 PMC: 8093600. DOI: 10.2217/pme-2019-0110.

Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?.

Chouchene S, Dabboubi R, Raddaoui H, Abroug H, Ben Hamda K, Hadj Fredj S Eur J Clin Pharmacol. 2018; 74(12):1567-1574.

PMID: 30073432 DOI: 10.1007/s00228-018-2530-5.

References

Scordo M, Caputi A, DArrigo C, Fava G, Spina E . Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol Res. 2004; 50(2):195-200. DOI: 10.1016/j.phrs.2004.01.004. View

Yousef A, Bulatova N, Newman W, Hakooz N, Ismail S, Qusa H . Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Mol Biol Rep. 2012; 39(10):9423-33. DOI: 10.1007/s11033-012-1807-5. View

Sibbing D, Koch W, Gebhard D, Schuster T, Braun S, Stegherr J . Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation. 2010; 121(4):512-8. DOI: 10.1161/CIRCULATIONAHA.109.885194. View

Gurbel P, Tantry U, Shuldiner A, Kereiakes D . Genotyping: one piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol. 2010; 56(2):112-6. DOI: 10.1016/j.jacc.2010.04.008. View

Yang J, Morin S, Verstuyft C, Fan L, Zhang Y, Xu C . Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations. Fundam Clin Pharmacol. 2003; 17(3):373-6. DOI: 10.1046/j.1472-8206.2003.00148.x. View

Suarez-Kurtz G . Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent. Eur J Clin Pharmacol. 2010; 67(2):211-2. DOI: 10.1007/s00228-010-0910-6. View

Kim K, Song W, Kim K, Park J . Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles. J Clin Pharm Ther. 2010; 35(6):697-703. DOI: 10.1111/j.1365-2710.2009.01069.x. View

Vicente J, Gonzalez-Andrade F, Soriano A, Fanlo A, Martinez-Jarreta B, Sinues B . Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study. Mol Biol Rep. 2014; 41(3):1267-72. DOI: 10.1007/s11033-013-2971-y. View

Goldstein J, Ishizaki T, Chiba K, de Morais S, Bell D, Krahn P . Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics. 1997; 7(1):59-64. DOI: 10.1097/00008571-199702000-00008. View

10.

Hamdy S, Hiratsuka M, Narahara K, El-Enany M, Moursi N, Mizugaki M . Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. Br J Clin Pharmacol. 2002; 53(6):596-603. PMC: 1874334. DOI: 10.1046/j.1365-2125.2002.01604.x. View

11.

Dandara C, Lombard Z, Du Plooy I, McLellan T, Norris S, Ramsay M . Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity. Pharmacogenomics. 2011; 12(12):1663-70. DOI: 10.2217/pgs.11.106. View

12.

Kudzi W, Dodoo A, Mills J . Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. BMC Med Genet. 2009; 10:124. PMC: 3224726. DOI: 10.1186/1471-2350-10-124. View

13.

Pedersen R, Brasch-Andersen C, Sim S, Bergmann T, Halling J, Petersen M . Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations. Eur J Clin Pharmacol. 2010; 66(12):1199-205. DOI: 10.1007/s00228-010-0864-8. View

14.

Kurose K, Sugiyama E, Saito Y . Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2011; 27(1):9-54. DOI: 10.2133/dmpk.dmpk-11-rv-111. View

15.

Ninomiya H, Mamiya K, Matsuo S, Ieiri I, Higuchi S, Tashiro N . Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication. Ther Drug Monit. 2000; 22(2):230-2. DOI: 10.1097/00007691-200004000-00016. View

16.

Persson I, Aklillu E, Rodrigues F, Bertilsson L, Ingelman-Sundberg M . S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians. Pharmacogenetics. 1996; 6(6):521-6. DOI: 10.1097/00008571-199612000-00005. View

17.

Allabi A, Gala J, Desager J, Heusterspreute M, Horsmans Y . Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations. Br J Clin Pharmacol. 2003; 56(6):653-7. PMC: 1884305. DOI: 10.1046/j.1365-2125.2003.01937.x. View

18.

Alzahrani A, Ragia G, Hanieh H, Manolopoulos V . Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia. Biomed Res Int. 2013; 2013:315980. PMC: 3613048. DOI: 10.1155/2013/315980. View

19.

Azarpira N, Namazi S, Hendijani F, Banan M, Darai M . Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran. Pharmacol Rep. 2010; 62(4):740-6. DOI: 10.1016/s1734-1140(10)70332-7. View